::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

INCIDENCE AND TREATMENT OF OBESITY ASSOCIATED HYPERTENSION

AUTHORS:

Dr Aqeela Jabeen, Dr Anam Azam, Dr Muhammad Mudassar Sattar

ABSTRACT:

Background: Obesity is a serious health problem and its increasing rate raises important issues specific to the coexisting development of related diseases, especially hypertension. This study looked at the prevalence of obesity-related hypertension, identifying the optimal treatment regimen for an obese hypertensive patient, and determining the relationship between hypertension and obesity by using body mass index and waist circumference. Methodology: A question-based study was conducted in outpatient department of Medicine Unit-II of Holy Family Hospital, Rawalpindi for one-year duration from August 2019 to August 2020. Interviews were conducted with 150 patients. The sampling technique was convenient random sampling. Results: A total of 150 respondents to this study were 40% male and 60% female. With a mean body mass index (BMI), 48% of respondents were overweight and 33% were obese class I. The average waist circumference is greater in women (more than 88 cm) than in men (less than 102 cm). Most of the prescribed drugs are (22%) NSAIDs, (18%) statins, (11%) beta blockers, (11%) nitrates, (11%) ARBs, and calcium channel blockers, loop diuretics, platelet inhibitors, benzodiazepines and tricyclic antidepressants were less prescribed. Conclusion: Obesity-related hypertension is more common among women, and there is a positive correlation between body mass index (BMI), waist circumference, and hypertension. Key words: obesity, hypertension, body mass index, waist circumference.